D

Devyser Diagnostics AB
F:OL0

Watchlist Manager
Devyser Diagnostics AB
F:OL0
Watchlist
Price: 10.22 EUR -1.16% Market Closed
Market Cap: 165.2m EUR

Devyser Diagnostics AB
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Devyser Diagnostics AB
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Revenue
kr216.9m
CAGR 3-Years
32%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Revenue
kr1.5B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Revenue
kr1.1B
CAGR 3-Years
57%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Revenue
kr3.5B
CAGR 3-Years
7%
CAGR 5-Years
22%
CAGR 10-Years
18%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Revenue
kr27.9B
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
24%
BioArctic AB
STO:BIOA B
Revenue
kr257.4m
CAGR 3-Years
123%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
173.7m EUR
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

OL0 Intrinsic Value
16.74 EUR
Undervaluation 39%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Revenue?
Revenue
216.9m SEK

Based on the financial report for Dec 31, 2024, Devyser Diagnostics AB's Revenue amounts to 216.9m SEK.

What is Devyser Diagnostics AB's Revenue growth rate?
Revenue CAGR 5Y
28%

Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Devyser Diagnostics AB have been 32% over the past three years , 28% over the past five years .

Back to Top